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1. Introduction 
Thymidine kinase activity (EC 2.7.1.75) exhibits 
periodic changes in macroplasmodia of Physantm 
polycephalum correlated with the synchronous 
nuclear division cycle [ 1,2]. Studies with inhibitors 
of RNA and protein synthesis uggest that production 
of this enzyme is mainly restricted to a small segment 
(1 h) of the 10 h nuclear cycle starting shortly prior 
to the onset of the synchronous mitosis [3]. Prelimi- 
nary attempts to isolate the enzyme from plasmodial 
extracts have shown that thymidine kinase activity 
appears in several fractions behaving differently during 
purification procedures. This communication reports 
on the separation of at least three enzyme variants by 
isoelectric focusing. The absolute and relative quan- 
tities of these variants change characteristically during 
the synchronous mitotic cycle. The results uggest 
that during the induction period a single enzyme 
species is produced which undergoes post-transcrip- 
tional modifications giving rise to multiple enzyme 
variants. 
2. Methods 
2.1 .Preparation of plasmodial extracts and assay of 
enzyme activity 
Disc shaped macroplasmodia of Physarum poly- 
cephalum (strain M3b) with a diameter of 2-5 cm 
were cultivated on a sterile liquid medium as described 
[4,5]. Entire plasmodia were harvested at selected 
stages of the mitotic cycle, frozen in dry ice together 
with 2-5 ml 50 mM TGM buffer (50 mM Tris-HCl, 
North-Holland Publishing Company -Amsterdam 
pH 7.5 at 25”C, 25% w/v glycerol, 5 mM 2-mer- 
captoethanol) and stored at -25°C. Frozen samples 
were quickly thawed, disrupted with a Potter-Elvehjem 
homogeniser and centrifuged for 1 h at 150 000 X g. 
Thymidine kinase activity and protein were deter- 
mined in the supernatant. The enzyme assay mixture 
(total volume 70 ~1) contained 86 mM Tris-HCl pH 
7.5, 8.7 mM ATP-Na, 8.7 mM MgClz , 2.6 mM 
EDTA-Na, 3.6 mM mercaptoethanol, 2.5 mg/ml bovine 
serum albumin, 18% w/v glycerol, 3.6 PM [ l4 C] thymi- 
dine (60 mCi/mmol, 0.215 pCi/ml), and plasmodial 
extract (0.5-1.0 mg protein/ml); aliquots (20 pl) 
were pipetted onto pieces of anion exchange paper 
(Whatman DE 81; 1.6 X i.0 cm) after 0, 15, and 30 min 
incubation at 26’C and processed as described [1,2]. 
The amount of [ l4 C] thymidine phosphorylated and 
retained on the paper was measured by liquid 
scintillation counting. 
2.2. Isoelectric focusing 
5% acrylamide gels (0.5 X 7.0 or 0.5 X 8.0 cm) 
containing 10% glycerol, 1.5% Ampholine (pH 
3.5-10.0) 1.5% Ampholine (pH 5.0-8.0), and 0.2% 
N,N’-methylenebisacrylamide were polymerised for 
20 min in glass tubes after the addition of 0.067% 
N,N,M,N’-tetramethylethylenediamine and 0.067% 
ammonium persulfate. Isoelectric focusing was 
performed for 6 h at 4°C in an apparatus essentially 
as described by Righetti and Drysdale [6], using 10 mM 
H3P04 as anolyte (bottom) and 20 mM NaOH as 
catholyte (top). In order to remove xcess persulfate 
the gels were pretreated for 45 min at 1 ma/tube. 
20 ~1 of plasmodial extract were applied to each gel, 
mixed with 5 ~1 Ampholine (15%, pH 3.5- 10.0) and 
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covered with 50 r.ll of a mixture of 10% w/v glycerol 
and 3% Ampholine (pH 3.5-10.0). Isoelectric focusing 
was started with 1 mA/tube; the voltage increased up 
to 500 V within 1 h and was kept constant at this level 
until the end of the run. Gels were frozen in dry ice 
for 1 h and sliced with a razor blade cutter into 2 mm 
sections. The slices were incubated for 15 h at 26’C 
in small plastic vials containing 100 ~1 of thymidine 
kinase assay mixture (0.13 M Tris-HCl, pH 7.5; 12.4 
mM ATP-Na, 12.4 mM MgCl*, 5 PM [‘*Cl thymidine 
60 mCi/mmol, 3.6 mM EDTA-Na, 3 mM mercapto- 
ethanol, 6.5 mg/ml bovine serum albumin, and 15% 
w/v glycerol). The reaction was terminated by pipetting 
aliquots of 20 /._LI onto pieces of Whatman DE-81 paper 
which were processed as described above. The pH gra- 
dient was determined in a control gel with a glass 
electrode after incubating groups of 2 slices in 1 ml 
distilled water for 15 h. 
3. Results and discussion 
Analysis of crude plasmodial extracts by isoelectric 
focusing on polyacrylamide gels demonstrates the 
existence of several fractions with thymidine kinase 
activity (fig. 1). At least three peaks are separated with 
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Fig. 1. Isoelectric focusing in 5% polyacrylamide gels. 
Individual plasmodia were harvested at time points indicated 
by arrows (a,b,c,d), homogenised with 2 ml (a,b) or 3 ml 
(c,d) 50 mM TGM buffer, and processed as described under 
‘Methods’. 20 ~1 samples (20-30 rg protein) were analysed 
by isoelectric focusing (7 cm gels). 
100 
E 
50 
0 
100 
E 
50 
( 
Fig.2. Repeated isoelectric focusing of peak fractions (A) and 
(C). 20 rl of a plasmodial extract (telophase) were processed 
as in fig. 1. Individual gel slices were incubated with 75 /.d 
50 mM TGM buffer at 0°C for 6 h and analysed for thymidine 
kinase activity using 25 ~1 aliquots. 30 pl of the peak fractions 
(A) and (C) were rerun on 2 separate gels (8 cm) under the 
same conditions as the original whole extract. The distribu- 
tion of enzyme activity in these gels, as well as the pH 
gradient in a control gel, were determined as in tig.1. 
isoelectric points at pH 7.8 f 0.15 (A), pH 6.7 + 0.1 
(B), and pH 6.3 + 0.1 (C). Small shoulders appear 
consistently at pH 7.2 and pH 5.9. The main fractions 
(A) and (C) behave as single peaks when eluted from 
the gel and analysed again by isoelectric focusing 
(fig.2). This indicates that (A) and (C) represent 
individual enzyme species with different physico- 
chemical properties rather than artefacts generated by 
the separation procedure. 
The absolute and relative amounts of thymidine 
kinase variants change drastically during the mitotic 
cycle (fig.l,3). Fraction (C) increases sharply during 
mitosis reaching a distinct maximum at telophase. 
Fractions (A) and (B) increase with a significant delay 
relative to (C) and continue to increase during S-phase 
concomitantly with a rapid drop of(C). Fraction (A) 
becomes the dominant species later on in the cycle 
whereas(C) virtually disappears in G?-period. (B) 
comprises lo- 15% of the total activity throughout 
the cycle. 
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Fig.3. Changes of total thymidine kinase activity and of enzyme 
variants during the synchronous nuclear division cycle. 24 
replicate macroplasmodia were prepared. Entire plasmodia 
were harvested at various time intervals, starting 1.5 h prior to 
the expected second synchronous mitosis. 20 ~1 samples 
(20-60 ,ug protein) of the high speed supernatants were 
immediately taken for isoelectric focusing; 50 r.11 aliquots were 
analysed for total thymidine kinase activity and protein 
respectively. The distribution of enzyme activity in the gels 
was determined and plotted as in tig.1. The contents of 
enzyme variants (A), (B), and (C) per plasmodium were com- 
puted from the areas under the corresponding peaks. 
Inset: Recovery of enzyme activity from gels after isoelectric 
focusing. Abscissa: enzyme activity (rU) of whole plasmodial 
extracts (20 ~1) applied to each gel. Ordinate: relative amount 
of enzyme product formed by incubating gel slices for 15 h 
with radioactive substrate; each point represents the radio- 
activity (cpm) measured in 20 ~1 aliquots/slice and summed for 
all slices of each gel. 
The sequential appearence of thymidine kinase 
variants in the mitotic cycle suggests, that fraction (C) 
is produced ‘de novo’ during the induction period and 
functions as a precursor for variant (A) and possibly 
also for(B). This is supported by the observation that 
the pattern of enzyme variants in plasmodial extracts 
changes similarly in vitro as in the living plasmodium 
(fig.4): the relative content of fraction (C) in crude 
plasmodial extracts obtained from plasmodia at the 
time of mitosis decreases during storage in the cold, 
whereas (A) increases concomitantly. Most likely this 
indicates a spontaneous transformation of enzyme 
variant(C) into variant (A). Preliminary observations 
suggest hat this process depends on a factor (enzyme ?) 
present in the crude plasmodial extract, since no 
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Fig.4. In vitro changes of thymidine kinase enzyme variants. 
The high speed supernatant obtained from a single macro- 
plasmodium at telophase 3 was stored at 0°C. Aliquots 
(20 ~1,40 pg protein) were analysed at various time intervals 
by isoelectric focusing and the distribution of enzyme activity 
in the gels was determined as in fig.1. The areas under the 
peaks (A), (B), and (C) are plotted as well as the total activity 
recovered from each gel. 
transformation is observed during storage of a 
partially purified fraction (C) [Grobner and Sachsen- 
maier, in preparation]. 
Multiple forms of thymidine kinase have been 
observed in several systems. In mammalian cells 
different isoenzymes were found in the cytosol 
and in mitochondria [7,8] . New species of thymidine 
kinase were identified after viral infection; certain 
Herpes viruses appear to code for a new virus specific 
thymidine kinase, whereas other viruses may derepress 
cellular genes (SV40, human adenoviruses) [9,10]. 
Different thymidine kinase isoenzyme patterns have 
also been linked to different developmental stages, 
malignant transformation, and low or high prolifera- 
tive activity [ 1 I-161. These differences have been 
discussed in terms of different genetic expression, i.e. 
introduction of viral genes or activation and re- 
pression of pre-existing cellular genes. By contrast, 
the observations reported here strongly suggest hat 
at least in some cases variants of thymidine kinase 
may arise from post-transcriptional modification of an 
unstable primary enzyme species. The cycle dependent 
variation of the isocnzyme pattern in Physarum appears 
as a direct consequence of the discontinuous production 
of a ‘precursor’-enzyme. A similar situation may also 
exist in mammalian cells. The cycle dependent 
thymidine kinase pattern observed in partially syn- 
chronised human kidney cells by Adler and McAuslan 
[ 171 would agree with the assumption that a single 
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thymidine kinase gene is activated discontinuously at 
the onset of the S-period followed by post-transcrip- 
tional modifications of the enzyme during later stages 
of the cycle. 
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